These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 26937187

  • 1. Exacerbations of COPD.
    Pavord ID, Jones PW, Burgel PR, Rabe KF.
    Int J Chron Obstruct Pulmon Dis; 2016; 11 Spec Iss(Spec Iss):21-30. PubMed ID: 26937187
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Acute exacerbations of chronic obstructive pulmonary disease].
    Chabot F, Gomez E, Guillaumot A, Kheir A, Chaouat A.
    Presse Med; 2009 Mar; 38(3):485-95. PubMed ID: 19185446
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impact and prevention of severe exacerbations of COPD: a review of the evidence.
    Halpin DM, Miravitlles M, Metzdorf N, Celli B.
    Int J Chron Obstruct Pulmon Dis; 2017 Mar; 12():2891-2908. PubMed ID: 29062228
    [Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression.
    Oba Y, Lone NA.
    Ther Adv Respir Dis; 2015 Feb; 9(1):3-15. PubMed ID: 25586493
    [Abstract] [Full Text] [Related]

  • 7. How should we define and classify exacerbations in chronic obstructive pulmonary disease?
    Trigueros Carrero JA.
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):33-41. PubMed ID: 23551022
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, Nordestgaard BG.
    JAMA; 2013 Jun 12; 309(22):2353-61. PubMed ID: 23757083
    [Abstract] [Full Text] [Related]

  • 12. COPD: it is time to change!
    Tantucci C, Pini L.
    Int J Chron Obstruct Pulmon Dis; 2015 Jun 12; 10():2451-7. PubMed ID: 26648707
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA, Donaldson GC.
    Respir Care; 2003 Dec 12; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [Abstract] [Full Text] [Related]

  • 15. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
    Abdool-Gaffar MS, Ambaram A, Ainslie GM, Bolliger CT, Feldman C, Geffen L, Irusen EM, Joubert J, Lalloo UG, Mabaso TT, Nyamande K, O'Brien J, Otto W, Raine R, Richards G, Smith C, Stickells D, Venter A, Visser S, Wong M, COPD Working Group.
    S Afr Med J; 2011 Jan 12; 101(1 Pt 2):63-73. PubMed ID: 21526617
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The clinical and integrated management of COPD.
    Bettoncelli G, Blasi F, Brusasco V, Centanni S, Corrado A, De Benedetto F, De Michele F, Di Maria GU, Donner CF, Falcone F, Mereu C, Nardini S, Pasqua F, Polverino M, Rossi A, Sanguinetti CM.
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 May 12; 31 Suppl 1():3-21. PubMed ID: 24820963
    [Abstract] [Full Text] [Related]

  • 19. Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD.
    Vijayasaratha K, Stockley RA.
    Int J Chron Obstruct Pulmon Dis; 2012 May 12; 7():789-96. PubMed ID: 23226015
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.